[{"address1": "4000 Shoreline Court", "address2": "Suite 300", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 822 5600", "website": "https://www.kezarlifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher J. Kirk Ph.D.", "age": 52, "title": "Co-Founder, CEO & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 927300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Franklin Fowler", "age": 52, "title": "Co-Founder & Director", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 57037, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc L. Belsky CPA", "age": 69, "title": "CFO & Secretary", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 653208, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Schiller", "age": 44, "title": "Chief Operations Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 637985, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Taunton Ph.D.", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pattie  Chiang", "age": 62, "title": "Principal Accounting Officer, Senior VP & Corporate Controller", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joe  Tedrick", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neel K. Anand Ph.D.", "title": "Senior Vice President of Research & Drug Discovery", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Zung  To", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Peterson FACR, M.D.", "title": "Head of Clinical Immunology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.4, "open": 4.45, "dayLow": 4.16, "dayHigh": 4.47, "regularMarketPreviousClose": 4.4, "regularMarketOpen": 4.45, "regularMarketDayLow": 4.16, "regularMarketDayHigh": 4.47, "payoutRatio": 0.0, "beta": 0.621, "forwardPE": -0.40305632, "volume": 19895, "regularMarketVolume": 19895, "averageVolume": 53443, "averageVolume10days": 58700, "averageDailyVolume10Day": 58700, "bid": 4.16, "ask": 4.29, "bidSize": 1, "askSize": 1, "marketCap": 30903506, "fiftyTwoWeekLow": 3.53, "fiftyTwoWeekHigh": 8.9, "allTimeHigh": 363.3, "allTimeLow": 3.53, "fiftyDayAverage": 3.934, "twoHundredDayAverage": 4.8233, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -57872492, "profitMargins": 0.0, "floatShares": 4314261, "sharesOutstanding": 7323106, "sharesShort": 758648, "sharesShortPriorMonth": 799726, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.103599995, "heldPercentInsiders": 0.10569999, "heldPercentInstitutions": 0.63956, "shortRatio": 18.09, "shortPercentOfFloat": 0.1058, "impliedSharesOutstanding": 7323106, "bookValue": 12.546, "priceToBook": 0.33636218, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -70791000, "trailingEps": -9.7, "forwardEps": -10.47, "lastSplitFactor": "1:10", "lastSplitDate": 1730246400, "enterpriseToEbitda": 0.774, "52WeekChange": -0.5149425, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 4.22, "targetHighPrice": 18.0, "targetLowPrice": 7.0, "targetMeanPrice": 12.5, "targetMedianPrice": 12.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 100849000, "totalCashPerShare": 13.771, "ebitda": -74738000, "totalDebt": 12073000, "quickRatio": 7.159, "currentRatio": 7.289, "debtToEquity": 13.153, "returnOnAssets": -0.32759, "returnOnEquity": -0.58391, "grossProfits": -54035000, "freeCashflow": -42026000, "operatingCashflow": -64304000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "KZR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1760129440, "regularMarketTime": 1760126401, "earningsTimestampStart": 1763150400, "earningsTimestampEnd": 1763150400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -9.7, "epsForward": -10.47, "epsCurrentYear": -7.53333, "priceEpsCurrentYear": -0.5601772, "fiftyDayAverageChange": 0.28599977, "fiftyDayAverageChangePercent": 0.07269949, "twoHundredDayAverageChange": -0.6033001, "twoHundredDayAverageChangePercent": -0.12508036, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "longName": "Kezar Life Sciences, Inc.", "shortName": "Kezar Life Sciences, Inc.", "exchange": "NCM", "messageBoardId": "finmb_304157325", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.09092, "regularMarketPrice": 4.22, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": 4.22038, "postMarketPrice": 4.3981, "postMarketChange": 0.1781, "regularMarketChange": -0.18, "regularMarketDayRange": "4.16 - 4.47", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 53443, "fiftyTwoWeekLowChange": 0.6899998, "fiftyTwoWeekLowChangePercent": 0.19546737, "fiftyTwoWeekRange": "3.53 - 8.9", "fiftyTwoWeekHighChange": -4.68, "fiftyTwoWeekHighChangePercent": -0.5258427, "fiftyTwoWeekChangePercent": -51.49425, "displayName": "Kezar Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]